Patent strategy in Drug repurposing

With an authorized repurposed medicine as the ultimate goal in focus, step by step and day by day executing essential steps of your strategy is key. These steps include the design of your preclinical R&D program relating to the new indication, selection of relevant and informative disease models, clinical trial design, and more, such as the stringent management of the what and when of the publication of the clinical trial protocol. During each aspect and step, one of the essentials is assessing whether and how your IP should be secured by filing patent applications on the right time. This, for example, as part of the purpose of raising the funds required for executing (phase III) clinical trials and more in general, having the resources for running your business. In addition, IP protection can be of utmost relevance for building a viable business model, especially when reimbursement is relatively on the low side.